Association of Suppressive Myeloid Cell Enrichment with Aggressive Oropharynx Squamous Cell Carcinoma
Authors:
- Changlin YangCYChanglin Yang
- Rekha GargRGRekha Garg
- Kristanna FredenburgKFKristanna Fredenburg
- Frances WeidertFWFrances Weidert
- Hector Mendez-GomezHMHector Mendez-Gomez
- Robert AmdurRARobert Amdur
- Ji-Hyun LeeJLJi-Hyun Lee
- Jamie KuJKJamie Ku
- Jesse KresakJKJesse Kresak
- Stephanie StarasSSStephanie Staras
- Andrew G. SikoraASAndrew G. Sikora
- Lily WangLWLily Wang
Open Access
Abstract
Background: While immune-cell infiltrated tumors, such as human papillomavirus positive (HPV+) ororpharyngeal squamous cell carcinomas (OPSCC) have been associated with an improved clinical prognosis, there is evidence to suggest that OPSCCs are also subjected to increased immunoregulatory influence. The objective of this study was to assess whether patients with clinically aggressive OPSCC have a distinct immunosuppressive immune signature in the primary tumor. Methods: This retrospective case-control study analyzed 37 pre-treatment tissue samples from HPV+ and HPV-negative OPSCC patients treated at a single institution. The cases were patients with known disease recurrence and the controls were patients without disease recurrence. An mRNA-expression immune-pathway profiling was performed, and correlated to clinical outcomes. The TCGA head and neck cancer database was utilized to make comparisons with the institutional cohort. Results: In our cohort, HPV-negative and HPV+ patients with known disease recurrence both had significantly increased suppressive monoctyte/macrophage and granulocyte cell-expression-profile enrichment. Similar findings were found in the TCGA cohort when comparing HPV-negative to positive patients. Conclusions: our study demonstrates that patients with recurrent HPV+ OPSCC had suppressive monocyte/macrophage and granulocyte immune-cell enrichment, similar to those seen in the more aggressive HPV-negative OPSCC.Keywords
Funding Information
- NIH/NIDCR (NIH5K08DE029503, 1U01DE028233-01)
- NCI/NIDCR sponsored (NIH5K08DE029503, 1U01DE028233-01)
This publication has 37 references indexed in Scilit:
- Validation of Methods for Oropharyngeal Cancer HPV Status Determination in US Cooperative Group TrialsAmerican Journal of Surgical Pathology, 2012
- Tobacco Smoking and Increased Risk of Death and Progression for Patients With p16-Positive and p16-Negative Oropharyngeal CancerJournal of Clinical Oncology, 2012
- Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United StatesJournal of Clinical Oncology, 2011
- p16INK4a overexpression predicts translational active human papillomavirus infection in tonsillar cancerInternational Journal of Cancer, 2010
- Human Papillomavirus and Survival of Patients with Oropharyngeal CancerNew England Journal of Medicine, 2010
- Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus‐associated head and neck cancer based on a prospective clinical experienceCancer, 2010
- Head and neck squamous cell cancer and the human papillomavirus: Summary of a National Cancer Institute State of the Science Meeting, November 9–10, 2008, Washington, D.C.Head & Neck, 2009
- Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical OutcomeScience, 2006
- GenePattern 2.0Nature Genetics, 2006
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005